Key result
Patients of African and Asian descent exhibit different cardiovascular risk profiles and medication responses compared to Europeans, necessitating lower statin doses for Asians and avoiding ACE-inhibitor monotherapy in Africans.
Why the study?
Do patients of African or Asian ancestry have different cardiovascular risk profiles and responses to cardiovascular medications compared to Europeans?
Population
Patients of African, South Asian, or East Asian ancestry with or at risk for diabetes and cardiovascular…
Comparison
Cardiovascular risk reduction therapies… vs Patients of European/Caucasian ancestry.
Design
Systematic_review
Authors
Loading...
Requires ancestry-specific statin dosing and ACE-inhibitor selection; extends evidence for ethnicity-tailored cardiovascular guidelines.
Do patients of African or Asian ancestry have different cardiovascular risk profiles and responses to cardiovascular medications compared to Europeans?
Ethnicity significantly impacts cardiovascular risk profiles and drug responses, necessitating tailored pharmacological treatments such as lower statin doses for Asians and avoiding ACE inhibitor monotherapy in patients of African descent.
Aambø et al. (2017) conducted a review in Cardiovascular disease and diabetes. Cardiovascular medications (statins, antihypertensives) vs. Caucasians/Europeans was evaluated. Patients of African and Asian descent exhibit different cardiovascular risk profiles and medication responses compared to Europeans, necessitating lower statin doses for Asians and avoiding ACE-inhibitor monotherapy in Africans.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: